Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? Squillace N, Pozzi MR, Gustinetti G, Ricci E, et al. Clin Infect Dis 2020 Sep 4. pii: 5901570. doi: 10.1093/cid/ciaa1282.

Read + Share

Amedeo Smart

Independent Medical Education

Squillace N, Pozzi MR, Gustinetti G, Ricci E, et al. Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? Clin Infect Dis 2020 Sep 4. pii: 5901570. doi: 10.1093/cid/ciaa1282.
PMID: 32886768